FDA Clearance Tracker · P240011-S010
Altaviva
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 13, 2026
Approved
Time to decision
144 days
Received Feb 19, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P240011-S010
- Device name
- Altaviva
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Feb 19, 2026
- Decided
- Jul 13, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P240011
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of updated labeling for the Altaviva system to incorporate the 24-month results from the TITAN 2 clinical study.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.